Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$991M |
| 2 |
Broadcom
AVGO
|
+$941M |
| 3 |
SPYM
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$859M |
| 4 |
Amazon
AMZN
|
+$858M |
| 5 |
iShares 3-7 Year Treasury Bond ETF
IEI
|
+$756M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$425M |
| 2 |
Merck
MRK
|
+$379M |
| 3 |
ASML
ASML
|
+$336M |
| 4 |
Yum China
YUMC
|
+$311M |
| 5 |
Microchip Technology
MCHP
|
+$306M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.73% |
| 2 | Financials | 12.43% |
| 3 | Industrials | 11.73% |
| 4 | Healthcare | 10.66% |
| 5 | Consumer Discretionary | 10.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3426
Aehr Test Systems
AEHR
$3.78B
| $191K | ﹤0.01% |
14,835
-17,288
| -54% | -$250K |
|
3427
Zentalis Pharmaceuticals
ZNTL
$297M
| $189K | ﹤0.01% |
51,462
-2,347
| -4% | -$8.53K |
|
3428
Getty Images
GETY
$118M
| $187K | ﹤0.01% |
48,963
+549
| +1% | +$1.94K |
|
3429
Capricor Therapeutics
CAPR
$225M
| $185K | ﹤0.01% |
12,178
+44
| +0.4% | +$218 |
|
3430
Neumora Therapeutics
NMRA
$308M
| $184K | ﹤0.01% |
13,907
+462
| +3% | +$5.39K |
|
3431
Microvast
MVST
$281M
| $183K | ﹤0.01% |
735,445
+51,603
| +8% | +$17.2K |
|
3432
Pulse Biosciences
PLSE
$3.18B
| $183K | ﹤0.01% |
10,429
-382
| -4% | -$6.51K |
|
|
FUND
3433
Sprott Focus Trust
FUND
$317M
| $183K | ﹤0.01% |
23,721
-26,396
| -53% | -$204K |
|
3434
Evolv Technologies
EVLV
$1.08B
| $181K | ﹤0.01% |
44,734
+715
| +2% | +$2.5K |
|
3435
Olema Pharmaceuticals
OLMA
$901M
| $181K | ﹤0.01% |
15,155
-327
| -2% | -$4.18K |
|
|
DADA
3436
DELISTED
Dada Nexus
DADA
| $180K | ﹤0.01% |
94,865
-525,824
| -85% | -$689K |
|
3437
Scholar Rock
SRRK
$6.34B
| $180K | ﹤0.01% |
22,413
+403
| +2% | +$3.54K |
|
3438
MaxCyte
MXCT
$134M
| $176K | ﹤0.01% |
45,248
-222
| -0.5% | -$935 |
|
3439
Noodles & Co
NDLS
$95.1M
| $175K | ﹤0.01% |
18,270
+81
| +0.4% | +$983 |
|
3440
Alector
ALEC
$228M
| $175K | ﹤0.01% |
37,580
+1,092
| +3% | +$5.86K |
|
3441
KLX Energy Services
KLXE
$31.4M
| $175K | ﹤0.01% |
31,984
+135
| +0.4% | +$817 |
|
3442
Talkspace
TALK
$869M
| $174K | ﹤0.01% |
83,358
+24,034
| +41% | +$46.9K |
|
3443
Taysha Gene Therapies
TSHA
$1.88B
| $172K | ﹤0.01% |
85,681
-312,069
| -78% | -$685K |
|
|
TERN
3444
DELISTED
Terns Pharmaceuticals
TERN
| $172K | ﹤0.01% |
20,647
-654
| -3% | -$5.38K |
|
|
KC
3445
Kingsoft Cloud Holdings
KC
$3.53B
| $170K | ﹤0.01% |
57,977
-3,647
| -6% | -$9.03K |
|
3446
CorMedix
CRMD
$573M
| $169K | ﹤0.01% |
20,919
-631
| -3% | -$3.42K |
|
|
KALV
3447
DELISTED
KalVista Pharmaceuticals
KALV
| $169K | ﹤0.01% |
14,557
+277
| +2% | +$3.48K |
|
|
FNA
3448
DELISTED
Paragon 28, Inc.
FNA
| $167K | ﹤0.01% |
25,067
+258
| +1% | +$1.95K |
|
|
ZYXI
3449
DELISTED
Zynex
ZYXI
| $165K | ﹤0.01% |
20,204
-19,681
| -49% | -$166K |
|
3450
UroGen Pharma
URGN
$2.29B
| $163K | ﹤0.01% |
12,822
+1,159
| +10% | +$17.2K |
|
Similar funds
Invesco's Q3 2024 Portfolio in Review
As of Q3 2024, Invesco held 3,952 positions worth $518B, up 9.5% from $473B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Invesco's Q3 2024 filing shows 81 new, 1,757 increased, 1,790 reduced and 200 closed positions. Its largest new stake was iShares 3-7 Year Treasury Bond ETF: 6,397,900 shares worth $765M. The largest sale was Advanced Micro Devices, an estimated $425M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Financials and Industrials.
- Invesco's largest Q3 2024 buy was iShares 3-7 Year Treasury Bond ETF: 6,397,900 shares worth $765M.
- Invesco added most to Apple in Q3 2024, an estimated $991M increase.
- Invesco's biggest Q3 2024 reduction was Advanced Micro Devices, cutting an estimated $425M.
- Invesco fully exited WestRock Company in Q3 2024, selling an estimated $196M.
- Invesco's ten largest holdings make up 18% of its $518B portfolio in Q3 2024.
- Invesco opened 81 new positions and closed 200 in Q3 2024.
- Invesco's portfolio value rose 9.5% quarter-over-quarter to $518B.
Based on Invesco's 13F filing for Q3 2024, filed 12 Nov 2024.